Finite-Lived Intangible Assets, Accumulated Amortization
AbbVie Finite-Lived Intangible Assets, Accumulated Amortization increased by 4.0% to $43.92B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.4%, from $36.79B to $43.92B. Over 5 years (FY 2020 to FY 2025), Finite-Lived Intangible Assets, Accumulated Amortization shows an upward trend with a 23.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A rising balance relative to gross assets indicates an aging portfolio of intangible assets nearing the end of their useful lives.
Detailed definition
The cumulative amount of amortization expense recognized against finite-lived intangible assets since their acquisition...
Peer comparison
Standard accounting metric; peers with older acquisition cycles will show higher accumulated amortization relative to gross assets.
other_finite_lived_intangible_assets_accumulated_amortizationHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.47B | $20.36B | $22.15B | $23.99B | $25.78B | $27.74B | $29.65B | $31.54B | $33.61B | $26.47B | $28.03B | $29.89B | $31.15B | $33.09B | $34.88B | $36.79B | $38.76B | $40.45B | $42.23B | $43.92B |
| QoQ Change | — | +10.3% | +8.8% | +8.3% | +7.5% | +7.6% | +6.9% | +6.4% | +6.6% | -21.2% | +5.9% | +6.7% | +4.2% | +6.2% | +5.4% | +5.5% | +5.3% | +4.4% | +4.4% | +4.0% |
| YoY Change | — | — | — | — | +39.6% | +36.3% | +33.8% | +31.5% | +30.4% | -4.6% | -5.5% | -5.2% | -7.3% | +25.0% | +24.4% | +23.1% | +24.4% | +22.2% | +21.1% | +19.4% |
Finite-Lived Intangible Assets, Accumulated Amortization at Other Companies
Frequently Asked Questions
- What is AbbVie's finite-lived intangible assets, accumulated amortization?
- AbbVie (ABBV) reported finite-lived intangible assets, accumulated amortization of $43.92B in Q1 2026.
- How has AbbVie's finite-lived intangible assets, accumulated amortization changed year-over-year?
- AbbVie's finite-lived intangible assets, accumulated amortization increased by 19.4% year-over-year, from $36.79B to $43.92B.
- What is the long-term trend for AbbVie's finite-lived intangible assets, accumulated amortization?
- Over 5 years (2020 to 2025), AbbVie's finite-lived intangible assets, accumulated amortization has grown at a 23.8% compound annual growth rate (CAGR), from $14.54B to $42.23B.
- What does finite-lived intangible assets, accumulated amortization mean?
- The total amount of value written off from intangible assets over their useful lives.